de la Piedra, C., Alcaraz, A., Bellmunt, J., Meseguer, C., Gómez-Caamano, A., Ribal, M. J., . . . Morote, J. (2013). Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study. Nature Publishing Group.
Chicago Stili Alıntıde la Piedra, C., et al. Usefulness of Bone Turnover Markers As Predictors of Mortality Risk, Disease Progression and Skeletal-related Events Appearance in Patients With Prostate Cancer With Bone Metastases Following Treatment With Zoledronic Acid: TUGAMO Study. Nature Publishing Group, 2013.
MLA Alıntıde la Piedra, C., et al. Usefulness of Bone Turnover Markers As Predictors of Mortality Risk, Disease Progression and Skeletal-related Events Appearance in Patients With Prostate Cancer With Bone Metastases Following Treatment With Zoledronic Acid: TUGAMO Study. Nature Publishing Group, 2013.